The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.

"The future looks bright as far as a cure," one top HIV cure researcher told LGBTQ Nation.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced final data from the LATITUDE phase III trial, confirming its ...

Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.

South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative ...

King's College London researchers have created a unique collection of human stem cell models that could help to uncover why ...

Researchers have created 50 induced pluripotent stem cell lines from 18 people with HIV to model HIV infection in the laboratory.

Gilead Sciences, Inc. today announced details of new clinical and real-world data from its innovative HIV treatment and ...

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important in the context of low-resourced health settings, Africa's focus ...

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...

Kenya has taken a major step forward in its battle against new HIV infections after receiving its first shipment of the long-acting injectable HIV prevention drug, Lenacapavir.